H.R. 9559 · 119th Congress (2025–2027)
IBOGAINE Act
To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to Health
This bill’s path
This is H.R. 9559’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Morgan Luttrell (R-TX-8)
- Cosponsors
5 cosponsors
3 original · 2 later
- Rep. Jack Bergman (R-MI-1)· Original · Jun 30, 2026
- Rep. J. Luis Correa (D-CA-46)· Original · Jun 30, 2026
- Rep. Michael T. McCaul (R-TX-10)· Original · Jun 30, 2026
- Rep. Mike Collins (R-GA-10)· Later · Aug 31, 2026
- Rep. Sarah Elfreth (D-MD-3)· Later · Sep 15, 2026
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
▸ 2 committee actions · Jun 30, 2026 – Jul 17, 2026
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Veterans' Affairs, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Referred to Health
Referred to the Subcommittee on Health.
Sources
- Congress.gov action
- House committee actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (3)
IBOGAINE Act
Display title, Short title · Introduced in House
Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy Act
Short title · Introduced in House
To accelerate the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States, and for other purposes.
Official title · Introduced in House